Literature DB >> 18449862

Association study between the genetic polymorphisms of glutathione-related enzymes and schizophrenia in a Japanese population.

Daisuke Matsuzawa1, Kenji Hashimoto, Tasuku Hashimoto, Eiji Shimizu, Hiroyuki Watanabe, Yuko Fujita, Masaomi Iyo.   

Abstract

Several lines of evidence suggest that oxidative stress plays a role in the pathogenesis of schizophrenia, and that glutathione (GSH) plays a crucial role in antioxidant defense mechanisms. In this study, we performed association studies between GSH-related genes (GSTM1, GSTP1, GSTO1, GSTT1, GSTT2, GPX1, and GCLM) and schizophrenia in a Japanese population. The overall distributions of the genotypes and alleles of each gene were not different between schizophrenic patients and controls. Subjects with residual-type schizophrenia showed different distributions in the analysis of GSTM1 genotype and in the combination analysis of GSTs, GPX1, and GCLM genotypes although the small sample size should be considered as a limitation of this study. In addition, our findings revealed that there were large ethnic differences in the genotype distributions of those GSH-related genes. The present study suggests that GSH-related genes may not play a major role in the pathogenesis of schizophrenia in a Japanese population. However, a dysregulation of GSH metabolism may be one of the vulnerability factors contributing to the development of a certain type of schizophrenia, and it is likely that the ethnic background should be considered in further study for those GSH-related genes. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18449862     DOI: 10.1002/ajmg.b.30776

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  14 in total

Review 1.  Genetic association studies of antioxidant pathway genes and schizophrenia.

Authors:  Kodavali V Chowdari; Mikhil N Bamne; Vishwajit L Nimgaonkar
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

2.  Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia.

Authors:  Jeffrey K Yao; George G Dougherty; Ravinder D Reddy; Matcheri S Keshavan; Debra M Montrose; Wayne R Matson; Joseph McEvoy; Rima Kaddurah-Daouk
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

3.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

Review 4.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

5.  Association of SOD2, GPX1, CAT, and TNF genetic polymorphisms with oxidative stress, neurochemistry, psychopathology, and extrapyramidal symptoms in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Marko Saje; Katja Goričar; Vita Dolžan; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Neurochem Res       Date:  2012-12-02       Impact factor: 3.996

6.  Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia.

Authors:  Dongjun Dai; Yunliang Wang; Jiaojiao Yuan; Xingyu Zhou; Danjie Jiang; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-06-30

7.  Homozygous Deletion of Glutathione Peroxidase 1 and Aldehyde Dehydrogenase 1a1 Genes Is Not Associated with Schizophrenia-Like Behavior in Mice.

Authors:  Xiang Bai; Elizabeth Fermandez; Georgianna Gould; Randy Strong
Journal:  J Biochem Pharmacol Res       Date:  2013-12-01

8.  Association study of schizophrenia with variants in miR-137 binding sites.

Authors:  David Curtis; Warren Emmett
Journal:  Schizophr Res       Date:  2017-11-20       Impact factor: 4.939

9.  Glutathione S-Transferase Deletion Polymorphisms in Early-Onset Psychotic and Bipolar Disorders: A Case-Control Study.

Authors:  Milica M Pejovic-Milovancevic; Vanja D Mandic-Maravic; Vesna M Coric; Marija M Mitkovic-Voncina; Milutin V Kostic; Ana R Savic-Radojevic; Marko D Ercegovac; Marija G Matic; Amir N Peljto; Dusica R Lecic-Tosevski; Tatjana P Simic; Marija S Pljesa-Ercegovac
Journal:  Lab Med       Date:  2016-04-25

10.  Associations between purine metabolites and clinical symptoms in schizophrenia.

Authors:  Jeffrey K Yao; Ruth Condray; George G Dougherty; Matcheri S Keshavan; Debra M Montrose; Wayne R Matson; Joseph McEvoy; Rima Kaddurah-Daouk; Ravinder D Reddy
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.